AHCPR COVERS TWO-THIRDS OF MOST COSTLY DIAGNOSES FOR MEDICARE PATIENTS, HHS ASH LEE SAYS; REP. THOMAS NOTES GOP SUPPORT FOR USE OF MEDICARE TRUST FUND
Clinical practice guidelines and patient outcomes research teams supported by HHS' Agency for Health Care Policy & Research address 10 of the 15 most costly diagnoses for which Medicare patients are hospitalized, HHS Assistant Secretary for Health Philip Lee, MD, told the House Ways & Means/Health Subcommittee at a March 21 hearing. Lee noted that these conditions account for about 80% of the amount billed by hospitals to the Medicare program.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth